OBJECTIVE: @entity661 ( @entity661 ) is characterized by transient apical @entity67 typically induced by acute stress. Acute cerebral events including @entity385 ( @entity385 ) or @entity302 events (EEs) may be associated with massive @entity5733 release. We aimed to identify the characteristics and outcomes of @entity1 who experienced the @entity661 complicated by @entity385 or @entity5202 . METHODS: Between 2008 and 2013, 87 @entity1 were admitted to our intensive care unit for @entity661 . Of these, 6 had previously experienced acute cerebral symptoms within 2 days of experiencing either @entity385 or @entity5202 . @entity661 was diagnosed on cardiac MRI, echocardiography, electrocardiography (ECG), biology and coronary angiography data. RESULTS: Five @entity1 and 1 @entity1 were included in the study. The mean age was 63.7    20.1 years (range 44-84). Four of them (67%) initially presented an acute @entity385 and 2 (33%) had @entity5202 . The suspected @entity1545 was found in the insular cortex for 4 @entity1 and the posterior fossa for 2 @entity1 . @entity1269 , @entity2026 and cerebellar symptoms were the main neurological signs. Abnormal ECG findings including ST-segment elevation (33%) or T-wave inversion (50%) developed between a few hours and 48 h after the onset of the @entity385 or @entity5202 . Peak troponin was 1.8 (0.79-14.11)   g/l. A transient reduction in the left ventricular ejection fraction (46    12%) with apical hypokinesis was found using echocardiography. Two (33%) @entity1 went on to develop @entity712 . Coronary angiography confirmed the lack of significant @entity3979 for all 6 @entity1 . CONCLUSION: @entity661 can develop within the first few days after an acute cerebral event. It occurs predominantly in @entity1 with insular or posterior fossa lesions and is possibly induced by vegetative reactions.

XXXX Following Acute Cerebral Events.

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'man'] @entity1545 :: ('MESH:D020214', 'Disease') :: ['brain injury'] @entity712 :: ('MESH:D006333', 'Disease') :: ['acute heart failure'] @entity5202 :: ('MESH:D057765', 'Disease') :: ['EE'] @entity5733 :: ('D002395', 'Chemical') :: ['catecholamine'] @entity1269 :: ('MESH:D010291', 'Disease') :: ['Hemiparesis'] @entity2026 :: ('MESH:D001037', 'Disease') :: ['aphasia'] @entity3979 :: ('MESH:D023921', 'Disease') :: ['coronary stenosis'] @entity661 :: ('MESH:D054549', 'Disease') :: ['Takotsubo syndrome', 'TCM', 'Takotsubo cardiomyopathy'] @entity302 :: ('MESH:D004827', 'Disease') :: ['epileptic'] @entity67 :: ('MESH:D018754', 'Disease') :: ['ventricular dysfunction'] @entity385 :: ('MESH:D002544', 'Disease') :: ['ischemic stroke', 'IS']
@entity661 :: (MESH:D054549,Disease) :: ['Takotsubo Cardiomyopathy']
